Stoke Therapeutics Inc. (STOK)
7.38
-0.47 (-5.99%)
At close: Mar 03, 2025, 3:59 PM
7.40
0.20%
After-hours: Mar 03, 2025, 04:00 PM EST
Stoke Therapeutics Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 191.44M | 113.56M | 144.9M | 287.31M | 222.47M | 105.4M | 1.8M |
Short-Term Investments | 9.95M | 116.04M | 74.92M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 569K | 569K | 205K | 205K | 204K | 56K |
Other Long-Term Assets | 569K | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 64K | 588K | 132K | 6K | 281K | 196K | n/a |
Inventory | n/a | 10.93M | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 13.88M | 13.89M | 9.28M | 6.62M | 6.56M | 548K | 113K |
Total Current Assets | 215.34M | 244.07M | 229.22M | 293.93M | 226.03M | 106.14M | 1.91M |
Property-Plant & Equipment | 12.43M | 11.43M | 9.08M | 3.79M | 2.51M | 1.19M | 473K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 13M | 12M | 9.65M | 4M | 2.72M | 1.4M | 529K |
Total Assets | 228.34M | 256.07M | 238.87M | 297.93M | 228.75M | 107.54M | 2.44M |
Account Payables | 1.7M | 766K | 2.38M | 1.5M | 751K | 1.07M | 141K |
Deferred Revenue | 15.31M | 14.88M | 12.71M | -1.07M | n/a | n/a | -3M |
Short-Term Debt | 2.39M | 2.36M | 1.51M | 1.07M | n/a | n/a | 3M |
Other Current Liabilities | 11.75M | 13.39M | 13.25M | 8.86M | 3.35M | 1.4M | 574K |
Total Current Liabilities | 30.82M | 31.39M | 17.14M | 11.43M | 4.1M | 2.47M | 3.71M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 4.88M | 2.97M | 3.95M | 422K | 221K | 4K | 16K |
Total Long-Term Liabilities | 37.96M | 39.82M | 3.95M | 422K | 221K | 4K | 16K |
Total Liabilities | 68.78M | 71.22M | 21.09M | 11.85M | 4.32M | 2.47M | 3.73M |
Total Debt | 2.06M | 2.36M | 1.51M | 80K | n/a | n/a | 3M |
Common Stock | 5K | 4K | 4K | 4K | 3K | 1K | 1K |
Retained Earnings | -401.85M | -297.15M | -196.08M | -110.28M | -58.03M | -25.71M | -13.19M |
Comprehensive Income | -24K | -1.18M | -168K | -0.00 | 0.00 | -379K | -172K |
Shareholders Equity | 159.56M | 184.85M | 217.78M | 286.08M | 224.43M | 105.07M | -1.29M |
Total Investments | 9.95M | 116.04M | 74.92M | 205K | 205K | 204K | 56K |